share_log

US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results

US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results

美國股票走勢不一;Abbott報告超出預期的第三季度業績
Benzinga ·  2024/10/16 22:03

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday.

今天上午美國股市漲跌互現,道瓊斯指數週三上漲約20點。

The Dow traded up 0.05% to 42,762.18 while the NASDAQ fell 0.06% to 18,305.30. The S&P 500 also fell, dropping, 0.07% to 5,811.21.

道瓊斯指數上漲0.05%,至42,762.18點,而納斯達克指數下跌0.06%,至18,305.30點。標準普爾500指數也下跌了0.07%,至5,811.21。

Leading and Lagging Sectors
Financials shares jumped by 0.7% on Wednesday.

領先和落後行業
週三,金融股上漲了0.7%。

In trading on Wednesday, communication services shares fell by 0.7%.

在週三的交易中,通信服務股下跌了0.7%。

Top Headline

熱門標題

On Wednesday, Abbott Laboratories (NYSE:ABT) reported better-than-expected third-quarter results.

週三,雅培實驗室(紐約證券交易所代碼:ABT)公佈的第三季度業績好於預期。

The company posted sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20.

該公司公佈的銷售額爲106.4億美元,同比增長4.9%,超過了預期的105.5億美元。雅培調整後的攤薄後每股收益爲1.21美元,超過了分析師預期的1.20美元。

Equities Trading UP

股票交易上漲

  • 180 Life Sciences Corp (NASDAQ:ATNF) shares shot up 668% to $11.73. 180 Life Sciences interim CEO said that the company is planning to enter the online gaming industry with its newly acquired gaming technology platform.
  • Shares of Santech Holdings Limited (NASDAQ:STEC) got a boost, surging 592% to $2.50.
  • Versus Systems Inc. (NASDAQ:VS) shares were also up, gaining 422% to $5.90 after the company announced a $2.5 million investment and licensing agreement with ASPIS.
  • 180生命科學公司(納斯達克股票代碼:ATNF)股價飆升668%,至11.73美元。180生命科學臨時首席執行官表示,該公司計劃通過其新收購的遊戲技術平台進入在線遊戲行業。
  • Santech Holdings Limited(納斯達克股票代碼:STEC)的股價上漲了592%,至2.50美元。
  • Versus Systems Inc.(納斯達克股票代碼:VS)的股價也上漲了422%,至5.90美元,此前該公司宣佈與ASPIS簽訂了250萬美元的投資和許可協議。

Equities Trading DOWN

股票交易下跌

  • Bright Minds Biosciences Inc (NASDAQ:DRUG) shares dropped 39% to $23.39. Firefly Neuroscience collaborated with Bright Minds Biosciences to analyze the data from its positive Phase 1 study using its Artificial Intelligence.
  • Shares of Silvaco Group, Inc. (NASDAQ:SVCO) were down 28% to $7.94 after the company reported a decline in orders from Asia during third quarter and cut its FY24 revenue outlook.
  • Zapata Computing Holdings Inc. (NASDAQ:ZPTA) was down, falling 26% to $0.09.
  • Bright Minds Biosciences Inc(納斯達克股票代碼:DRUG)股價下跌39%,至23.Firefly Neuroscience與Bright Minds Biosciences合作,使用其人工智能分析了其積極的1期研究的數據。
  • Silvaco集團公司(納斯達克股票代碼:SVCO)的股價下跌28%,至7.94美元,此前該公司報告第三季度來自亞洲的訂單下降並下調了24財年的收入展望。
  • 扎帕塔計算機控股公司(納斯達克股票代碼:ZPTA)下跌26%,至0.09美元。

Commodities
In commodity news, oil traded down 0.1% to $70.53 while gold traded up 0.8% at $2,700.00.

大宗商品
在大宗商品新聞方面,石油價格下跌0.1%,至70.53美元,而黃金上漲0.8%,至2700.00美元。

Silver traded up 1.8% to $32.325 on Wednesday, while copper rose 0.8% to $4.3725.

週三,白銀上漲1.8%,至32.325美元,銅價上漲0.8%,至4.3725美元。

Euro zone

歐元區

European shares were mixed today. The eurozone's STOXX 600 slipped 0.2%, Germany's DAX slipped 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 gained 0.9%.

今天歐洲股市漲跌互現。歐元區斯托克600指數下跌0.2%,德國DAX指數下跌0.2%,法國CAC 40指數下跌0.5%。西班牙的IBEX 35指數上漲0.4%,而倫敦富時100指數上漲0.9%。

Asia Pacific Markets

亞太市場

Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 1.83%, Hong Kong's Hang Seng Index falling 0.16%, China's Shanghai Composite Index gaining 0.05% and India's BSE Sensex falling 0.39%.

週三亞洲市場收盤大多走低,日本日經225指數下跌1.83%,香港恒生指數下跌0.16%,中國上證綜合指數上漲0.05%,印度BSE Sensex下跌0.39%。

Economics

經濟學

  • U.S. mortgage applications fell by 17% from the previous week during the second week of October.
  • Export prices in the U.S. declined by 0.7% month-over-month in September, exceeding market estimates of a 0.4% fall.
  • Import prices declined by 0.4% from the previous month in September.
  • 在10月的第二週,美國抵押貸款申請較前一週下降了17%。
  • 美國9月份的出口價格同比下降0.7%,超過了市場預期的0.4%的跌幅。
  • 9月份的進口價格比上個月下降了0.4%。

Now Read This:

現在讀這個:

  • Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
  • 吉姆·克萊默:「我們需要更多的鈾」,推薦這隻股票;諾和諾德對大型製藥公司的競爭對手說 「不相提並論」
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論